<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37446047</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>13</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10874</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241310874</ELocationID><Abstract><AbstractText>For over three years, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents has generated repercussions, especially a few weeks after infection, for symptomatic patients who tested positive, for asymptomatic ones, or even just the contacts of an infected person, and evolved from severe forms such as multisystem inflammatory syndrome in children (MIS-C) to multifarious clinical manifestations in long COVID (LC). Referred to under the umbrella term LC, the onset of persistent and highly heterogeneous symptoms such as fatigue, post-exertion malaise, cognitive dysfunction, and others have a major impact on the child's daily quality of life for months. The first aim of this review was to highlight the circumstances of the pathophysiological changes produced by COVID-19 in children and to better understand the hyperinflammation in COVID-19 and how MIS-C, as a life-threatening condition, could have been avoided in some patients. Another goal was to better identify the interplay between infection, dysbiosis, and inflammation at a molecular and cellular level, to better guide scientists, physicians, and pediatricians to advance new lines of medical action to avoid the post-acute sequelae of SARS-CoV-2 infection. The third objective was to identify symptoms and their connection to molecular pathways to recognize LC more easily. The fourth purpose was to connect the triggering factors of LC with related sequelae following acute SARS-CoV-2 injuries to systems and organs, the persistence of the virus, and some of its components in hidden reservoirs, including the gut and the central nervous system. The reactivation of other latent infectious agents in the host's immune environments, the interaction of this virus with the microbiome, immune hyperactivation, and autoimmunity generated by molecular mimicry between viral agents and host proteins, could initiate a targeted and individualized management. New high-tech solutions, molecules, probiotics, and others should be discovered to innovatively solve the interplay between RNA persistent viruses, microbiota, and our immune system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ailioaie</LastName><ForeName>Laura Marinela</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-8067-5184</Identifier><AffiliationInfo><Affiliation>Department of Medical Physics, Alexandru Ioan Cuza University, 11 Carol I Boulevard, 700506 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ailioaie</LastName><ForeName>Constantin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Physics, Alexandru Ioan Cuza University, 11 Carol I Boulevard, 700506 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Litscher</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6287-0130</Identifier><AffiliationInfo><Affiliation>President of the International Society for Medical Laser Applications (ISLA Transcontinental), German Vice President of the German-Chinese Research Foundation (DCFG) for TCM, Honorary President of the European Federation of Acupuncture and Moxibustion Societies, 8053 Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE-2</Keyword><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">gut</Keyword><Keyword MajorTopicYN="N">hyperinflammation</Keyword><Keyword MajorTopicYN="N">immune imbalance</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">mimicry</Keyword><Keyword MajorTopicYN="N">permanent tissue damage</Keyword><Keyword MajorTopicYN="N">post-infectious</Keyword><Keyword MajorTopicYN="N">viral persistence</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37446047</ArticleId><ArticleId IdType="pmc">PMC10342011</ArticleId><ArticleId IdType="doi">10.3390/ijms241310874</ArticleId><ArticleId IdType="pii">ijms241310874</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The World Health Organization  International Health Regulations (2005)&#x2013;Third Edition.  [(accessed on 10 April 2023)].  Available online:  https://www.who.int/publications/i/item/9789241580496.</Citation></Reference><Reference><Citation>Gostin L.O., Katz R. The International Health Regulations: The Governing Framework for Global Health Security. Milbank Q. 2016;94:264&#x2013;313. doi: 10.1111/1468-0009.12186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.12186</ArticleId><ArticleId IdType="pmc">PMC4911720</ArticleId><ArticleId IdType="pubmed">27166578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A., Osman S. Public health emergencies of international concern: A historic overview. J. Travel Med. 2020;27:taaa227. doi: 10.1093/jtm/taaa227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taaa227</ArticleId><ArticleId IdType="pmc">PMC7798963</ArticleId><ArticleId IdType="pubmed">33284964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi C., Alsafi Z., O&#x2019;Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., Agha R. World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19) Int. J. Surg. 2020;76:71&#x2013;76. doi: 10.1016/j.ijsu.2020.02.034. Erratum in Int. J. Surg.&#xa0;2020, 77, 217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.02.034</ArticleId><ArticleId IdType="pmc">PMC7105032</ArticleId><ArticleId IdType="pubmed">32112977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Yu B., Chen X., Rich S., Mo Q., Yan H. Dynamics of the coronavirus disease 2019 (COVID-19) epidemic in Wuhan City, Hubei Province and China: A second derivative analysis of the cumulative daily diagnosed cases during the first 85 days. Glob. Health J. 2021;5:4&#x2013;11. doi: 10.1016/j.glohj.2021.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.glohj.2021.02.001</ArticleId><ArticleId IdType="pmc">PMC7866847</ArticleId><ArticleId IdType="pubmed">33585050</ArticleId></ArticleIdList></Reference><Reference><Citation>Worobey M., Levy J.I., Malpica Serrano L., Crits-Christoph A., Pekar J.E., Goldstein S.A., Rasmussen A.L., Kraemer M.U.G., Newman C., Koopmans M.P.G., et al. The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic. Science. 2022;377:951&#x2013;959. doi: 10.1126/science.abp8715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abp8715</ArticleId><ArticleId IdType="pmc">PMC9348750</ArticleId><ArticleId IdType="pubmed">35881010</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Health Organization  Coronavirus disease (COVID-19) Pandemic.  [(accessed on 12 April 2023)].  Available online:  https://www.who.int/europe/emergencies/situations/covid-19.</Citation></Reference><Reference><Citation>National Library of Medicine. National Center for Biology Information  Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Wuhan-Hu-1, Complete Genome. GenBank: MN908947.3.  [(accessed on 12 April 2023)]; Available online:  https://www.ncbi.nlm.nih.gov/nuccore/MN908947.</Citation></Reference><Reference><Citation>Grellet E., L&#x2019;H&#xf4;te I., Goulet A., Imbert I. Replication of the coronavirus genome: A paradox among positive-strand RNA viruses. J. Biol. Chem. 2022;298:101923. doi: 10.1016/j.jbc.2022.101923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101923</ArticleId><ArticleId IdType="pmc">PMC8994683</ArticleId><ArticleId IdType="pubmed">35413290</ArticleId></ArticleIdList></Reference><Reference><Citation>Roland D., Gardiner A., Razzaq D., Rose K., Bressan S., Honeyford K., Buonsenso D., Da Dalt L., De T., Farrugia R., et al. Influence of epidemics and pandemics on paediatric ED use: A systematic review. Arch. Dis. Child. 2023;108:115&#x2013;122. doi: 10.1136/archdischild-2022-324108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-324108</ArticleId><ArticleId IdType="pubmed">36162959</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyone T., Aung T.T., Endericks T., Myint N.W., Inamdar L., Collins S., Pwint K.H., Hein B.B., Wilson A. Health system governance in strengthening International Health Regulations (IHR) compliance in Myanmar. BMJ Glob. Health. 2020;5:e003566. doi: 10.1136/bmjgh-2020-003566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-003566</ArticleId><ArticleId IdType="pmc">PMC7607592</ArticleId><ArticleId IdType="pubmed">33139302</ArticleId></ArticleIdList></Reference><Reference><Citation>Verikios G. The dynamic effects of infectious disease outbreaks: The case of pandemic influenza and human coronavirus. Socio-Econ. Plan. Sci. 2020;71:100898. doi: 10.1016/j.seps.2020.100898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seps.2020.100898</ArticleId><ArticleId IdType="pmc">PMC7286241</ArticleId><ArticleId IdType="pubmed">32834133</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli V., Cimini A., Ferri C. Cytokine Storm in COVID-19: &#x201c;When You Come Out of the Storm, You Won&#x2019;t Be the Same Person Who Walked in&#x201d;. Front. Immunol. 2020;11:2132. doi: 10.3389/fimmu.2020.02132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02132</ArticleId><ArticleId IdType="pmc">PMC7492381</ArticleId><ArticleId IdType="pubmed">32983172</ArticleId></ArticleIdList></Reference><Reference><Citation>Araf Y., Faruqui N.A., Anwar S., Hosen M.J. SARS-CoV-2: A new dimension to our understanding of coronaviruses. Int. Microbiol. 2021;24:19&#x2013;24. doi: 10.1007/s10123-020-00152-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10123-020-00152-y</ArticleId><ArticleId IdType="pmc">PMC7684150</ArticleId><ArticleId IdType="pubmed">33231780</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahabi M., Ghazanfari T., Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int. Immunopharmacol. 2022;112:109183. doi: 10.1016/j.intimp.2022.109183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109183</ArticleId><ArticleId IdType="pmc">PMC9393178</ArticleId><ArticleId IdType="pubmed">36182877</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavarzi A., Horry H.R. Bayesian estimation of a dynamic stochastic general equilibrium model with health disaster risk. Stoch. Environ. Res. Risk Assess. 2023;37:1199&#x2013;1211. doi: 10.1007/s00477-022-02357-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00477-022-02357-1</ArticleId><ArticleId IdType="pmc">PMC9857921</ArticleId><ArticleId IdType="pubmed">36714448</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R.  StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023.  [(accessed on 24 May 2023)]. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 9 January 2023. Available online:  https://pubmed.ncbi.nlm.nih.gov/32150360.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zebardast A., Hasanzadeh A., Ebrahimian Shiadeh S.A., Tourani M., Yahyapour Y. COVID-19: A trigger of autoimmune diseases. Cell Biol. Int. 2023;47:848&#x2013;858. doi: 10.1002/cbin.11997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11997</ArticleId><ArticleId IdType="pubmed">36740221</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 17 April 2023)].  Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  . COVID Data Tracker. US Department of Health and Human Services, CDC; Atlanta, GA, USA: 2023.  [(accessed on 17 April 2023)].  Available online:  https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance.</Citation></Reference><Reference><Citation>Ryan L., Pl&#xf6;tz F.B., van den Hoogen A., Latour J.M., Degtyareva M., Keuning M., Klingenberg C., Reiss I.K.M., Giannoni E., Roehr C., et al. Neonates and COVID-19: State of the art: Neonatal Sepsis series. Pediatr. Res. 2022;91:432&#x2013;439. doi: 10.1038/s41390-021-01875-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-021-01875-y</ArticleId><ArticleId IdType="pmc">PMC8712275</ArticleId><ArticleId IdType="pubmed">34961785</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafstrom C.E. Neurological effects of COVID-19 in infants and children. Dev. Med. Child Neurol. 2022;64:818&#x2013;829. doi: 10.1111/dmcn.15185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dmcn.15185</ArticleId><ArticleId IdType="pmc">PMC9111795</ArticleId><ArticleId IdType="pubmed">35243616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergia M., Sanchez-Marcos E., Gonzalez-Haba B., Hernaiz A.I., de Ceano-Vivas M., Garc&#xed;a L&#xf3;pez-Hortelano M., Garc&#xed;a-Garc&#xed;a M.L., Jimenez-Garc&#xed;a R., Calvo C. Comparative study shows that 1 in 7 Spanish children with COVID-19 symptoms were still experiencing issues after 12 weeks. Acta Paediatr. 2022;111:1573&#x2013;1582. doi: 10.1111/apa.16368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16368</ArticleId><ArticleId IdType="pmc">PMC9111513</ArticleId><ArticleId IdType="pubmed">35451112</ArticleId></ArticleIdList></Reference><Reference><Citation>Paw&#x142;owska M., Pokorska-&#x15a;piewak M., Talarek E., Mania A., Hasiec B., &#x17b;wirek-Pytka E., Stankiewicz M., Stani M., Fra&#x144;czak-Chmura P., Szenborn L., et al. Clinical Course and Severity of COVID-19 in 940 Infants with and without Comorbidities Hospitalized in 2020 and 2021: The Results of the National Multicenter Database SARSTer-PED. J. Clin. Med. 2023;12:2479. doi: 10.3390/jcm12072479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12072479</ArticleId><ArticleId IdType="pmc">PMC10095202</ArticleId><ArticleId IdType="pubmed">37048562</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Disease in Children and Adolescents: Scientific Brief, 29 September 2021.  [(accessed on 17 April 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Children_and_adolescents-2021.1.</Citation></Reference><Reference><Citation>Molloy E.J., Nakra N., Gale C., Dimitriades V.R., Lakshminrusimha S. Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: Optimizing definition and management. Pediatr. Res. 2023;93:1499&#x2013;1508. doi: 10.1038/s41390-022-02263-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02263-w</ArticleId><ArticleId IdType="pmc">PMC9436161</ArticleId><ArticleId IdType="pubmed">36050390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammett D.L., Loiselle C., Palmer K.M., Loiselle J.M., Attia M.W. COVID-19 Screening in the Pediatric Emergency Department. Cureus. 2023;15:e35731. doi: 10.7759/cureus.35731.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.35731</ArticleId><ArticleId IdType="pmc">PMC10066930</ArticleId><ArticleId IdType="pubmed">37016637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kammoun R., Masmoudi K. Paediatric aspects of COVID-19: An update. Respir. Med. Res. 2020;78:100765. doi: 10.1016/j.resmer.2020.100765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resmer.2020.100765</ArticleId><ArticleId IdType="pmc">PMC7212977</ArticleId><ArticleId IdType="pubmed">32504982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara J., Watanabe K., Takagi H., Sumitomo N., Kuno T. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis. Pediatr. Pulmonol. 2021;56:837&#x2013;848. doi: 10.1002/ppul.25245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25245</ArticleId><ArticleId IdType="pmc">PMC8013394</ArticleId><ArticleId IdType="pubmed">33428826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. Eur. J. Pediatr. 2021;180:2019&#x2013;2034. doi: 10.1007/s00431-021-03993-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03993-5</ArticleId><ArticleId IdType="pmc">PMC7890544</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId></ArticleIdList></Reference><Reference><Citation>Renson T., Forkert N.D., Amador K., Miettunen P., Parsons S.J., Dhalla M., Johnson N.A., Luca N., Schmeling H., Stevenson R., et al. Distinct phenotypes of multisystem inflammatory syndrome in children: A cohort study. Pediatr. Rheumatol. Online J. 2023;21:33. doi: 10.1186/s12969-023-00815-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-023-00815-w</ArticleId><ArticleId IdType="pmc">PMC10092941</ArticleId><ArticleId IdType="pubmed">37046304</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020;324:259&#x2013;269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravichandran S., Tang J., Grubbs G., Lee Y., Pourhashemi S., Hussaini L., Lapp S.A., Jerris R.C., Singh V., Chahroudi A., et al. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Nat. Immunol. 2021;22:1452&#x2013;1464. doi: 10.1038/s41590-021-01051-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01051-8</ArticleId><ArticleId IdType="pubmed">34611361</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiriard A., Meyer B., Eberhardt C.S., Loevy N., Grazioli S., Adouan W., Fontannaz P., Marechal F., L&#x2019;Huillier A.G., Siegrist C.A., et al. Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19. Front. Immunol. 2023;14:1107156. doi: 10.3389/fimmu.2023.1107156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1107156</ArticleId><ArticleId IdType="pmc">PMC10050384</ArticleId><ArticleId IdType="pubmed">37006315</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzinger F., Santiago-Garc&#xed;a B., Noguera-Juli&#xe1;n A., Lanaspa M., Lancella L., Cal&#xf2; Carducci F.I., Gabrovska N., Velizarova S., Prunk P., Osterman V., et al. COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study. Lancet Child Adolesc. Health. 2020;4:653&#x2013;661. doi: 10.1016/S2352-4642(20)30177-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30177-2</ArticleId><ArticleId IdType="pmc">PMC7316447</ArticleId><ArticleId IdType="pubmed">32593339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145:e20200702. doi: 10.1542/peds.2020-0702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0702</ArticleId><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz F.M. If Young Children&#x2019;s Risk of SARS-CoV-2 Infection Is Similar to That of Adults, Can Children Also Contribute to Household Transmission? JAMA Pediatr. 2022;176:19&#x2013;21. doi: 10.1001/jamapediatrics.2021.4225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.4225</ArticleId><ArticleId IdType="pubmed">34623387</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawood F.S., Porucznik C.A., Veguilla V., Stanford J.B., Duque J., Rolfes M.A., Dixon A., Thind P., Hacker E., Castro M.J.E., et al. Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York. JAMA Pediatr. 2022;176:59&#x2013;67. doi: 10.1001/jamapediatrics.2021.4217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.4217</ArticleId><ArticleId IdType="pmc">PMC8501415</ArticleId><ArticleId IdType="pubmed">34623377</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2. Erratum in Nat. Rev. Microbiol.&#xa0;2023, 21, 408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., Zhang A.X.D., O&#x2019;Mahoney L.L., Stephenson T.J., Ladhani S.N., De Stavola B.L., Viner R.M., Swann O.V. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J. Infect. 2022;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E., Callard F., Stras L., Melville-J&#xf3;hannesson B., Pope R., Alwan A.N. Why the Patient-Made Term &#x2018;Long Covid&#x2019; is needed [version 1; peer review: Awaiting peer review] Wellcome Open Res. 2020;5:224. doi: 10.12688/wellcomeopenres.16307.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16307.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr. Infect. Dis. J. 2021;40:e482&#x2013;e487. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner A.M., Robinson D.A., Yang L., Williams C.F., Newman L.M., Breen J.J., Eisinger R.W., Schneider J.S., Adimora A.A., Erbelding E.J. Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19. Ann. Intern. Med. 2021;174:999&#x2013;1003. doi: 10.7326/M21-1043.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1043</ArticleId><ArticleId IdType="pmc">PMC8025940</ArticleId><ArticleId IdType="pubmed">33780290</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH Experts Discuss Post-Acute COVID-19.  [(accessed on 8 April 2023)]; Available online:  https://www.nih.gov/news-events/news-releases/nih-experts-discuss-post-acute-covid-19.</Citation></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Long COVID or Post-COVID Conditions.  [(accessed on 8 April 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>WHO. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021.  [(accessed on 8 April 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18. (NICE Guideline, No. 188)  [(accessed on 16 May 2023)]; Available online:  https://www.ncbi.nlm.nih.gov/books/NBK567261/</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P.A. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect. Dis. 2020;12:ofaa509. doi: 10.1093/ofid/ofaa509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements W., Joseph T., Koukounaras J. UK NICE Guidelines for EVAR: Cost Implications for Post-COVID Australian Public Health. Cardiovasc. Interv. Radiol. 2021;44:1286&#x2013;1288. doi: 10.1007/s00270-021-02832-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-021-02832-2</ArticleId><ArticleId IdType="pubmed">33884459</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., Rojas N., Dalrymple E., Pinto Pereira S., Soni M., Knight M., Cheung E.Y., Heyman I., et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>A Clinical Case Definition for Post COVID-19 Condition in Children and Adolescents by Expert Consensus, 16 February 2023.  [(accessed on 7 April 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1.</Citation></Reference><Reference><Citation>Burki T. Clinical case definition of post-COVID-19 condition in children: A good start, but improvements are needed. Lancet Respir. Med. 2023;11:314. doi: 10.1016/S2213-2600(23)00081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00081-4</ArticleId><ArticleId IdType="pmc">PMC9991061</ArticleId><ArticleId IdType="pubmed">36898399</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M.Z., Yang M., Lai C.-L. Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis and Management. Viruses. 2023;15:533. doi: 10.3390/v15020533.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020533</ArticleId><ArticleId IdType="pmc">PMC9964207</ArticleId><ArticleId IdType="pubmed">36851746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110:914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L., Roge I., Pucuka Z., Pavare J. Clinical features of pediatric post-acute COVID-19: A descriptive retrospective follow-up study. Ital. J. Pediatr. 2021;47:177. doi: 10.1186/s13052-021-01127-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01127-z</ArticleId><ArticleId IdType="pmc">PMC8390049</ArticleId><ArticleId IdType="pubmed">34446085</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I., Smane L., Kivite-Urtane A., Pucuka Z., Racko I., Klavina L., Pavare J. Comparison of Persistent Symptoms After COVID-19 and Other Non-SARS-CoV-2 Infections in Children. Front. Pediatr. 2021;9:752385. doi: 10.3389/fped.2021.752385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385</ArticleId><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., Bhopal S.S., Hughes R.C., Antonelli M., Murray B., Kl&#xe4;ser K., Kerfoot E., Chen L., et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health. 2021;5:708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X. Erratum in Lancet Child Adolesc. Health. 2021, 5, e43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel M., Xie L., Kapera O., Mihalcea A., Kahn J., Messiah S.E. Long-term physical, mental and social health effects of COVID-19 in the pediatric population: A scoping review. World J. Pediatr. 2022;18:149&#x2013;159. doi: 10.1007/s12519-022-00515-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-022-00515-7</ArticleId><ArticleId IdType="pmc">PMC8812346</ArticleId><ArticleId IdType="pubmed">35118594</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasichkina E., Kofeynikova O., Fetisova S., Starshinova A.Y., Sheyanova E., Vershinina T., Ryzhkov A., Skripnik A., Alekseeva D., Nechaeva E., et al. Severe Course of COVID-19 and Long-COVID-19 in Children: Difficulties in Diagnosis. Life. 2023;13:781. doi: 10.3390/life13030781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13030781</ArticleId><ArticleId IdType="pmc">PMC10056761</ArticleId><ArticleId IdType="pubmed">36983936</ArticleId></ArticleIdList></Reference><Reference><Citation>Avittan H., Kustovs D. Cognition and Mental Health in Pediatric Patients Following COVID-19. Int. J. Environ. Res. Public Health. 2023;20:5061. doi: 10.3390/ijerph20065061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20065061</ArticleId><ArticleId IdType="pmc">PMC10049312</ArticleId><ArticleId IdType="pubmed">36981968</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapani G., Verlato G., Bertino E., Maiocco G., Vesentini R., Spadavecchia A., Dess&#xec; A., Fanos V. Long COVID-19 in children: An Italian cohort study. Ital. J. Pediatr. 2022;48:83. doi: 10.1186/s13052-022-01282-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01282-x</ArticleId><ArticleId IdType="pmc">PMC9163526</ArticleId><ArticleId IdType="pubmed">35659358</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F., Nguyen D.V., Navaratnam A.M., Shrotri M., Kovar J., Hayward A.C., Fragaszy E., Aldridge R.W., Hardelid P. VirusWatch Collaborative. Prevalence and Characteristics of Persistent Symptoms in Children During the COVID-19 Pandemic: Evidence from a Household Cohort Study in England and Wales. Pediatr. Infect. Dis. J. 2022;41:979&#x2013;984. doi: 10.1097/INF.0000000000003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003715</ArticleId><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S.9, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children-a nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauroux B., Sim&#xf5;es E.A.F., Checchia P.A., Paes B., Figueras-Aloy J., Manzoni P., Bont L., Carbonell-Estrany X. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infect. Dis. Ther. 2017;6:173&#x2013;197. doi: 10.1007/s40121-017-0151-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-017-0151-4</ArticleId><ArticleId IdType="pmc">PMC5446364</ArticleId><ArticleId IdType="pubmed">28357706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Tong L., Li M., Wang Y., Li L., Yang D., Zhang Y., Chen Z. Recurrent Wheezing and Asthma After Respiratory Syncytial Virus Bronchiolitis. Front. Pediatr. 2021;9:649003. doi: 10.3389/fped.2021.649003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.649003</ArticleId><ArticleId IdType="pmc">PMC8211724</ArticleId><ArticleId IdType="pubmed">34150683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fevang B., Wyller V.B.B., Mollnes T.E., Pedersen M., Asprusten T.T., Michelsen A., Ueland T., Otterdal K. Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection with Associations to Chronic Low-Grade Inflammation and Fatigue. Front. Immunol. 2021;12:715102. doi: 10.3389/fimmu.2021.715102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.715102</ArticleId><ArticleId IdType="pmc">PMC8721200</ArticleId><ArticleId IdType="pubmed">34987499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Palm P., Nygaard U., Bundgaard H., Petersen M.N.S., Rosenkilde S., Thorsted A.B., Ersb&#xf8;ll A.K., Thygesen L.C., Nielsen S.D., et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022;9:614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., Pazukhina E., Ricchiuto A., Sinatti D., Zona M., De Matteis A., D&#x2019;Ilario F., Gentili C., Lanni R., et al. Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol. Front. Pediatr. 2022;10:834875. doi: 10.3389/fped.2022.834875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pazukhina E., Gentili C., Vetrugno L., Morello R., Zona M., De Matteis A., D&#x2019;Ilario F., Lanni R., Rongai T., et al. The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy. J. Clin. Med. 2022;11:6772. doi: 10.3390/jcm11226772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11226772</ArticleId><ArticleId IdType="pmc">PMC9692851</ArticleId><ArticleId IdType="pubmed">36431250</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A., Janda A., Renk H., Stich M., Frieh P., Kaier K., Lohrmann F., Nieters A., Willems A., Huzly D., et al. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. EBioMedicine. 2022;84:104245. doi: 10.1016/j.ebiom.2022.104245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ven D., Bulu&#x15f; A.D. Clinical and laboratory predictors of long-COVID in children: A single center retrospective study. Eur. Rev. Med. Pharmacol. Sci. 2022;26:7695&#x2013;7704. doi: 10.26355/eurrev_202210_30046.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202210_30046</ArticleId><ArticleId IdType="pubmed">36314341</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., de Stavola B.L., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;Mahoney L., Chalder T., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0. Erratum in Lancet Child Adolesc. Health&#xa0;2022, 6, e21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczborska K., Buda P., Ksi&#x105;&#x17c;yk J. Long-COVID in immunocompromised children. Eur. J. Pediatr. 2022;181:3501&#x2013;3509. doi: 10.1007/s00431-022-04561-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04561-1</ArticleId><ArticleId IdType="pmc">PMC9281224</ArticleId><ArticleId IdType="pubmed">35834042</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilser D. Long Covid/Post-COVID-19-Syndrom bei Kindern und Jugendlichen. P&#xe4;diatrie. 2022;34:20&#x2013;25. doi: 10.1007/s15014-022-4024-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15014-022-4024-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostev K., Smith L., Koyanagi A., Konrad M., Jacob L. Post-COVID-19 conditions in children and adolescents diagnosed with COVID-19. Pediatr. Res. 2022:1&#x2013;6. doi: 10.1038/s41390-022-02111-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02111-x</ArticleId><ArticleId IdType="pmc">PMC9107066</ArticleId><ArticleId IdType="pubmed">35568733</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren-Gash C., Lacey A., Cook S., Stocker D., Toon S., Lelii F., Ford B., Ireland G., Ladhani S.N., Stephenson T., et al. COVID-19 Schools Infection Survey 2 Study Group (2023). Post-COVID-19 condition and persisting symptoms in English schoolchildren: Repeated surveys to March 2022. BMC Infect. Dis. 2023;23:201. doi: 10.1186/s12879-023-08203-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08203-1</ArticleId><ArticleId IdType="pmc">PMC10075149</ArticleId><ArticleId IdType="pubmed">37020190</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamaica Balderas L.M.D.C., Navarro Fern&#xe1;ndez A., Dragustinovis Garza S.A., Orellana Jerves M.I., Sol&#xed;s Figueroa W.E., Koretzky S.G., M&#xe1;rquez Gonz&#xe1;lez H., Kl&#xfc;nder Kl&#xfc;nder M., Espinosa J.G., Nieto Zerme&#xf1;o J., et al. Long COVID in children and adolescents: COVID-19 follow-up results in third-level pediatric hospital. Front. Pediatr. 2023;11:1016394. doi: 10.3389/fped.2023.1016394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1016394</ArticleId><ArticleId IdType="pmc">PMC9922986</ArticleId><ArticleId IdType="pubmed">36793333</ArticleId></ArticleIdList></Reference><Reference><Citation>Kara O.K., Cetin S.Y., Turker D., Y&#x131;k&#x131;lmaz S.K., Tamer S., Kara K. The long-term impact of the COVID-19 pandemic on children with ADHD in terms of participation, support, and barriers at home. J. Pediatr. Nurs. 2023;72:1&#x2013;8. doi: 10.1016/j.pedn.2023.03.009. Advance online publication.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedn.2023.03.009</ArticleId><ArticleId IdType="pmc">PMC10033257</ArticleId><ArticleId IdType="pubmed">37023560</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., R&#xe9;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugler Yonts A. Pediatric Long-COVID: A Review of the Definition, Epidemiology, Presentation, and Pathophysiology. Pediatr. Ann. 2022;51:e416&#x2013;e420. doi: 10.3928/19382359-20220913-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/19382359-20220913-06</ArticleId><ArticleId IdType="pubmed">36343180</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;pfner N., Alberer M., Ankermann T., Bender S., Berner R., de Laffolie J., Dingemann J., Heinicke D., Haas J.P., Hufnagel M., et al. Einheitliche Basisversorgung von Kindern und Jugendlichen mit Long COVID. Mon. Kinderheilkd. 2022;170:539&#x2013;547. doi: 10.1007/s00112-021-01408-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00112-021-01408-1</ArticleId><ArticleId IdType="pmc">PMC9131710</ArticleId><ArticleId IdType="pubmed">35637934</ArticleId></ArticleIdList></Reference><Reference><Citation>Goretzki S.C., Brasseler M., Dogan B., H&#xfc;hne T., Bernard D., Sch&#xf6;necker A., Steindor M., Gangfu&#xdf; A., Della Marina A., Felderhoff-M&#xfc;ser U., et al. High Prevalence of Alternative Diagnoses in Children and Adolescents with Suspected Long COVID&#x2014;A Single Center Cohort Study. Viruses. 2023;15:579. doi: 10.3390/v15020579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020579</ArticleId><ArticleId IdType="pmc">PMC9961131</ArticleId><ArticleId IdType="pubmed">36851793</ArticleId></ArticleIdList></Reference><Reference><Citation>Garai R., Kriv&#xe1;csy P., Herczeg V., Kov&#xe1;cs F., T&#xe9;l B., Kelemen J., M&#xe1;th&#xe9; A., Zs&#xe1;ry E., Tak&#xe1;cs J., Veres D.S., et al. Clinical assessment of children with long COVID syndrome. Pediatr. Res. 2023;93:1616&#x2013;1625. doi: 10.1038/s41390-022-02378-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02378-0</ArticleId><ArticleId IdType="pmc">PMC10172119</ArticleId><ArticleId IdType="pubmed">36474113</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho S.S., Sim&#xf5;es e Silva A.C., Sabino A.D.P., Evangelista F.C., Gomes K.B., Dusse L.M., Rios D.R. Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor &#x3b2;1 in Patients Undergoing Hemodialysis. PLoS ONE. 2016;11:e0150613. doi: 10.1371/journal.pone.0150613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150613</ArticleId><ArticleId IdType="pmc">PMC4811575</ArticleId><ArticleId IdType="pubmed">27022914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 2022;20:270&#x2013;284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.G., Falcoff N.L., Corradi G.R., Di Camillo N., Seguel R.F., Tabaj G.C., Guman G.R., de Matteo E., Nu&#xf1;ez M., Gironacci M.M. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels. Pediatr. Res. 2023;93:948&#x2013;952. doi: 10.1038/s41390-022-02163-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02163-z</ArticleId><ArticleId IdType="pmc">PMC9219367</ArticleId><ArticleId IdType="pubmed">35739259</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama S., Nagata N., Shirato K., Kawase M., Takeda M., Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 2010;84:12658&#x2013;12664. doi: 10.1128/JVI.01542-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01542-10</ArticleId><ArticleId IdType="pmc">PMC3004351</ArticleId><ArticleId IdType="pubmed">20926566</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007;128:92&#x2013;105. doi: 10.1016/j.mad.2006.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2006.11.016</ArticleId><ArticleId IdType="pubmed">17116321</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachim I.Y., Hachim M.Y., Talaat I.M., L&#xf3;pez-Ozuna V.M., Saheb Sharif-Askari N., Al Heialy S., Halwani R., Hamid Q. The Molecular Basis of Gender Variations in Mortality Rates Associated with the Novel Coronavirus (COVID-19) Outbreak. Front. Mol. Biosci. 2021;8:728409. doi: 10.3389/fmolb.2021.728409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.728409</ArticleId><ArticleId IdType="pmc">PMC8484873</ArticleId><ArticleId IdType="pubmed">34604307</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Zhu Y., Hong Y. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis. Hypertension. 2020;76:e13&#x2013;e14. doi: 10.1161/HYPERTENSIONAHA.120.15572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15572</ArticleId><ArticleId IdType="pubmed">32458694</ArticleId></ArticleIdList></Reference><Reference><Citation>Papola F., Biancofiore V., Angeletti C., Grimaldi A., Carucci A.C., Cofini V., Necozione S., Rosciano A., Marinangeli F., Cervelli C. Anti-AT1R autoantibodies and prediction of the severity of Covid-19. Hum. Immunol. 2022;83:130&#x2013;133. doi: 10.1016/j.humimm.2021.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2021.10.006</ArticleId><ArticleId IdType="pmc">PMC8577881</ArticleId><ArticleId IdType="pubmed">34772541</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastolla U., Chambers P., Abia D., Garcia-Bermejo M.-L., Fresno M. Is Covid-19 Severity Associated with ACE2 Degradation? Front. Drug. Discov. 2022;1:789710. doi: 10.3389/fddsv.2021.789710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fddsv.2021.789710</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID syndrome-associated brain fog. J. Med. Virol. 2022;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., Ladhani S.N. Long COVID in children and adolescents. Curr. Opin. Infect. Dis. 2022;35:461&#x2013;467. doi: 10.1097/QCO.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000854</ArticleId><ArticleId IdType="pmc">PMC9553244</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D.E. Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol. 2022;20:e3001687. doi: 10.1371/journal.pbio.3001687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001687</ArticleId><ArticleId IdType="pmc">PMC9191737</ArticleId><ArticleId IdType="pubmed">35648781</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo del Valle N.C., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. Sci. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong Z., Mai H., Kapoor S., Puelles G.V., Czogalla J., Sch&#xe4;dler J., Vering J., Delbridge C., Steinke H., Frenzel H., et al. SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19. bioRxiv. 2023 doi: 10.1101/2023.04.04.535604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.04.535604</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullard J.F., Lee H.C., Voloudakis G., Suo S., Javidfar B., Shao Z., Peter C., Zhang W., Jiang S., Corvelo A., et al. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19. Genome Med. 2021;13:118. doi: 10.1186/s13073-021-00933-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00933-8</ArticleId><ArticleId IdType="pmc">PMC8287557</ArticleId><ArticleId IdType="pubmed">34281603</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Kempuraj D. Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID. Cells. 2023;12:688. doi: 10.3390/cells12050688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050688</ArticleId><ArticleId IdType="pmc">PMC10001285</ArticleId><ArticleId IdType="pubmed">36899824</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J.J.L. Persistent SARS-2 infections contribute to long COVID-19. Med. Hypotheses. 2021;149:110538. doi: 10.1016/j.mehy.2021.110538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110538</ArticleId><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Casabianca M., Caula C., Titomanlio L., Lenglart L. Neurological consequences of SARS-CoV-2 infections in the pediatric population. Front. Pediatr. 2023;11:1123348. doi: 10.3389/fped.2023.1123348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1123348</ArticleId><ArticleId IdType="pmc">PMC9973732</ArticleId><ArticleId IdType="pubmed">36865695</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Rong L., Nian W., He Y. Review article: Gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment. Pharmacol. Ther. 2020;51:843&#x2013;851. doi: 10.1111/apt.15731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15731</ArticleId><ArticleId IdType="pmc">PMC7161803</ArticleId><ArticleId IdType="pubmed">32222988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Guan C., Chen R., Wang Y., Feng S., Wang R., Qu G., Zhao S., Wang F., Wang X., et al. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients. Cell. Mol. Immunol. 2021;18:487&#x2013;489. doi: 10.1038/s41423-020-00604-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00604-5</ArticleId><ArticleId IdType="pmc">PMC7734388</ArticleId><ArticleId IdType="pubmed">33318629</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherne M.D., Gentry A.B., Nemudraia A., Nemudryi A., Hedges J.F., Walk H., Blackwell K., Snyder D.T., Jerome M., Madden W., et al. Severe Acute Respiratory Syndrome Coronavirus 2 Is Detected in the Gastrointestinal Tract of Asymptomatic Endoscopy Patients but Is Unlikely to Pose a Significant Risk to Healthcare Personnel. Gastro Hep. Adv. 2022;1:844&#x2013;852. doi: 10.1016/j.gastha.2022.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastha.2022.06.002</ArticleId><ArticleId IdType="pmc">PMC9225937</ArticleId><ArticleId IdType="pubmed">35765598</ArticleId></ArticleIdList></Reference><Reference><Citation>Connelly Z.M., Whitaker D., Dullea A., Ramasamy R. SARS-CoV-2 Effects on the Male Genitourinary System. Am. J. Clin. Exp. Urol. 2022;10:199&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428573</ArticleId><ArticleId IdType="pubmed">36051611</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D., Castro K., Schwarz S., Vaidy K., Rabinowitz S., Wallach T.D. Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection. JPGN Rep. 2022;3:e152. doi: 10.1097/PG9.0000000000000152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PG9.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Tullie L., Ford K., Bisharat M., Watson T., Thakkar H., Mullassery D., Giuliani S., Blackburn S., Cross K., De Coppi P., et al. Gastrointestinal features in children with COVID-19: An observation of varied presentation in eight children. Lancet Child Adolesc. Health. 2020;4:e19&#x2013;e20. doi: 10.1016/S2352-4642(20)30165-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30165-6</ArticleId><ArticleId IdType="pmc">PMC7237361</ArticleId><ArticleId IdType="pubmed">32442420</ArticleId></ArticleIdList></Reference><Reference><Citation>Colmenero I., Santonja C., Alonso-Ria&#xf1;o M., Noguera-Morel L., Hern&#xe1;ndez-Mart&#xed;n A., Andina D., Wiesner T., Rodr&#xed;guez-Peralto J.L., Requena L., Torrelo A. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: Histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br. J. Dermatol. 2020;183:729&#x2013;737. doi: 10.1111/bjd.19327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19327</ArticleId><ArticleId IdType="pmc">PMC7323219</ArticleId><ArticleId IdType="pubmed">32562567</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainardi V., Meoli A., Chiopris G., Motta M., Skenderaj K., Grandinetti R., Bergomi A., Antodaro F., Zona S., Esposito S. Long COVID in Children and Adolescents. Life. 2022;12:285. doi: 10.3390/life12020285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020285</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W.T., Zhang Y., Liu M., Liu Y.Q., Ma X. Prolonged viral shedding in feces of children with COVID-19: A systematic review and synthesis of data. Eur. J. Pediatr. 2022;181:4011&#x2013;4017. doi: 10.1007/s00431-022-04622-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04622-5</ArticleId><ArticleId IdType="pmc">PMC9483442</ArticleId><ArticleId IdType="pubmed">36114833</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos V.S., Gurgel R.Q., Cuevas L.E., Martins-Filho P.R. Prolonged Fecal Shedding of SARS-CoV-2 in Pediatric Patients: A Quantitative Evidence Synthesis. J. Pediatr. Gastroenterol. Nutr. 2020;71:150&#x2013;152. doi: 10.1097/MPG.0000000000002798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000002798</ArticleId><ArticleId IdType="pmc">PMC7268855</ArticleId><ArticleId IdType="pubmed">32452978</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V., Mahajan A., Spikes L., Krishnamachary B., Ram A.K., Kumar A., Chen L., Chalise P., Dhillon N.K. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J. Med. Virol. 2023;95:e28568. doi: 10.1002/jmv.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang X.T.T., Kavishka J.M., Zhang D.X., Pirisinu M., Le M.T.N. Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery. Cells. 2020;9:2191. doi: 10.3390/cells9102191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102191</ArticleId><ArticleId IdType="pmc">PMC7600121</ArticleId><ArticleId IdType="pubmed">33003285</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Alanis A., Sandner-Miranda L., Delgado G., Cravioto A., Morales-Espinosa R. The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789. BMC Res. Notes. 2020;13:398. doi: 10.1186/s13104-020-05242-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-020-05242-8</ArticleId><ArticleId IdType="pmc">PMC7450963</ArticleId><ArticleId IdType="pubmed">32854762</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott T.A., Supramaniam A., Idris A., Cardoso A.A., Shrivastava S., Kelly G., Grepo N.A., Soemardy C., Ray R.M., McMillan N.A.J., et al. Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2. Mol. Ther. Methods Clin. Dev. 2022;24:355&#x2013;366. doi: 10.1016/j.omtm.2022.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.01.015</ArticleId><ArticleId IdType="pmc">PMC8806709</ArticleId><ArticleId IdType="pubmed">35127966</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotulo G.A., Palma P. Understanding COVID-19 in children: Immune determinants and post-infection conditions. Pediatr. Res. 2023 doi: 10.1038/s41390-023-02549-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-023-02549-7</ArticleId><ArticleId IdType="pmc">PMC9987407</ArticleId><ArticleId IdType="pubmed">36879079</ArticleId></ArticleIdList></Reference><Reference><Citation>Pou C., Nkulikiyimfura D., Henckel E., Olin A., Lakshmikanth T., Mikes J., Wang J., Chen Y., Bernhardsson A.K., Gustafsson A., et al. The repertoire of maternal anti-viral antibodies in human newborns. Nat. Med. 2019;25:591&#x2013;596. doi: 10.1038/s41591-019-0392-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0392-8</ArticleId><ArticleId IdType="pubmed">30886409</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch C.M., Prigge A.D., Anekalla K.R., Shukla A., Do Umehara H.C., Setar L., Chavez J., Abdala-Valencia H., Politanska Y., Markov N.S., et al. Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2. Am. J. Respir. Cell Mol. Biol. 2022;66:206&#x2013;222. doi: 10.1165/rcmb.2021-0292OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2021-0292OC</ArticleId><ArticleId IdType="pmc">PMC8845137</ArticleId><ArticleId IdType="pubmed">34731594</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. SARS-CoV-2 infections in children: Understanding diverse outcomes. Immunity. 2022;55:201&#x2013;209. doi: 10.1016/j.immuni.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8769938</ArticleId><ArticleId IdType="pubmed">35093190</ArticleId></ArticleIdList></Reference><Reference><Citation>Varchetta S., Mele D., Oliviero B., Mantovani S., Ludovisi S., Cerino A., Bruno R., Castelli A., Mosconi M., Vecchia M., et al. Unique immunological profile in patients with COVID-19. Cell. Mol. Immunol. 2021;18:604&#x2013;612. doi: 10.1038/s41423-020-00557-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00557-9</ArticleId><ArticleId IdType="pmc">PMC7557230</ArticleId><ArticleId IdType="pubmed">33060840</ArticleId></ArticleIdList></Reference><Reference><Citation>Abarca-Zabal&#xed;a J., Gonz&#xe1;lez-Jim&#xe9;nez A., Calle-Rubio M., L&#xf3;pez-Pastor A.R., Fari&#xf1;a T., Ramos-Acosta C., Anguita E., Urcelay E., Espino-Pais&#xe1;n L. Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients. Front. Immunol. 2023;14:1127352. doi: 10.3389/fimmu.2023.1127352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1127352</ArticleId><ArticleId IdType="pmc">PMC9969554</ArticleId><ArticleId IdType="pubmed">36860856</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Restrepo-Jim&#xe9;nez P., Monsalve D.M., Pacheco Y., Acosta-Ampudia Y., Ram&#xed;rez-Santana C., Leung P.S.C., Ansari A.A., Gershwin M.E., Anaya J.M. Molecular mimicry and autoimmunity. J. Autoimmun. 2018;95:100&#x2013;123. doi: 10.1016/j.jaut.2018.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.012</ArticleId><ArticleId IdType="pubmed">30509385</ArticleId></ArticleIdList></Reference><Reference><Citation>Caso F., Costa L., Ruscitti P., Navarini L., Del Puente A., Giacomelli R., Scarpa R. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun. Rev. 2020;19:102524. doi: 10.1016/j.autrev.2020.102524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102524</ArticleId><ArticleId IdType="pmc">PMC7271072</ArticleId><ArticleId IdType="pubmed">32220633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaresan B., Shirafkan F., Ripperger K., Rattay K. The Role of Viral Infections in the Onset of Autoimmune Diseases. Viruses. 2023;15:782. doi: 10.3390/v15030782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030782</ArticleId><ArticleId IdType="pmc">PMC10051805</ArticleId><ArticleId IdType="pubmed">36992490</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sante G., Buonsenso D., De Rose C., Valentini P., Ria F., Sanguinetti M., Sali M. Immune profile of children with post-acute sequelae of SARS-CoV-2 infection (Long COVID) medRxiv. 2021 doi: 10.1101/2021.05.07.21256539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.07.21256539</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Xiao J., Sun R., Tang X., Liang C., Lin H., Zeng L., Hu J., Yuan R., Zhou P., et al. Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids. Emerg. Infect. Dis. 2020;26:1834&#x2013;1838. doi: 10.3201/eid2608.201097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.201097</ArticleId><ArticleId IdType="pmc">PMC7392422</ArticleId><ArticleId IdType="pubmed">32383638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Yin Z., Xu J., Wang S., Liao T., Wang K., Li Y., Yang F., Wang Z., Yang G., et al. Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China. J. Infect. Dis. 2021;224:1473&#x2013;1488. doi: 10.1093/infdis/jiab181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab181</ArticleId><ArticleId IdType="pmc">PMC8083630</ArticleId><ArticleId IdType="pubmed">33822106</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2022;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumiya T., Ota K., Imaizumi T., Yoshida H., Kimura H., Satoh K. Characterization of synergistic induction of CX3CL1/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: An essential role for TNF-alpha in post-transcriptional regulation of CX3CL1. J. Immunol. 2010;184:4205&#x2013;4214. doi: 10.4049/jimmunol.0903212.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0903212</ArticleId><ArticleId IdType="pubmed">20231691</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M., Mildner A., Yona S. Developmental and Functional Heterogeneity of Monocytes. Immunity. 2018;49:595&#x2013;613. doi: 10.1016/j.immuni.2018.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.10.005</ArticleId><ArticleId IdType="pubmed">30332628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapellos T.S., Bonaguro L., Gem&#xfc;nd I., Reusch N., Saglam A., Hinkley E.R., Schultze J.L. Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. Front. Immunol. 2019;10:2035. doi: 10.3389/fimmu.2019.02035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02035</ArticleId><ArticleId IdType="pmc">PMC6728754</ArticleId><ArticleId IdType="pubmed">31543877</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Dean L.S., Jiyarom B., Gangcuangco L.M., Shah P., Awamura T., Ching L.L., Nerurkar V.R., Chow D.C., Igno F., et al. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals. Front. Immunol. 2023;14:1151780. doi: 10.3389/fimmu.2023.1151780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1151780</ArticleId><ArticleId IdType="pmc">PMC10106598</ArticleId><ArticleId IdType="pubmed">37077911</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowd J.B., Palermo T., Brite J., McDade T.W., Aiello A. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6&#x2013;19, 2003&#x2013;2010. PLoS ONE. 2013;8:e64921. doi: 10.1371/journal.pone.0064921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064921</ArticleId><ArticleId IdType="pmc">PMC3661547</ArticleId><ArticleId IdType="pubmed">23717674</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves M., Marinho-Dias J., Ribeiro J., Sousa H. Epstein-Barr virus strains and variations: Geographic or disease-specific variants? J. Med. Virol. 2017;89:373&#x2013;387. doi: 10.1002/jmv.24633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24633</ArticleId><ArticleId IdType="pubmed">27430663</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Houen G., Trier N.H. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front. Immunol. 2021;11:587380. doi: 10.3389/fimmu.2020.587380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.587380</ArticleId><ArticleId IdType="pmc">PMC7817975</ArticleId><ArticleId IdType="pubmed">33488588</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallanti S., Di Ponzio M. PANDAS/PANS in the COVID-19 Age: Autoimmunity and Epstein&#x2013;Barr Virus Reactivation as Trigger Agents? Children. 2023;10:648. doi: 10.3390/children10040648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children10040648</ArticleId><ArticleId IdType="pmc">PMC10136983</ArticleId><ArticleId IdType="pubmed">37189896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipollaro L., Giordano L., Padulo J., Oliva F., Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J. Orthop. Surg. Res. 2020;15:178. doi: 10.1186/s13018-020-01702-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-020-01702-w</ArticleId><ArticleId IdType="pmc">PMC7232908</ArticleId><ArticleId IdType="pubmed">32423471</ArticleId></ArticleIdList></Reference><Reference><Citation>Beydon M., Chevalier K., Al Tabaa O., Hamroun S., Delettre A.S., Thomas M., Herrou J., Riviere E., Mariette X. Myositis as a manifestation of SARS-CoV-2. Ann. Rheum. Dis. 2021;80:e42. doi: 10.1136/annrheumdis-2020-217573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217573</ArticleId><ArticleId IdType="pubmed">32327427</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano G.S., Woods J.K., Amato A.A. Covid-19-Associated Myopathy Caused by Type I Interferonopathy. N. Engl. J. Med. 2020;383:2389&#x2013;2390. doi: 10.1056/NEJMc2031085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031085</ArticleId><ArticleId IdType="pmc">PMC7722689</ArticleId><ArticleId IdType="pubmed">33216474</ArticleId></ArticleIdList></Reference><Reference><Citation>Movahedi N., Ziaee V. COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis? Pediatr. Rheumatol. 2021;19:86. doi: 10.1186/s12969-021-00570-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00570-w</ArticleId><ArticleId IdType="pmc">PMC8190732</ArticleId><ArticleId IdType="pubmed">34112199</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanboon J., Nishino I. COVID-19-associated myositis may be dermatomyositis. Muscle Nerve. 2021;63:E9&#x2013;E10. doi: 10.1002/mus.27105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27105</ArticleId><ArticleId IdType="pubmed">33095493</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian J., Xu H. COVID-19 Disease and Dermatomyositis: A Mini-Review. Front. Immunol. 2022;12:747116. doi: 10.3389/fimmu.2021.747116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.747116</ArticleId><ArticleId IdType="pmc">PMC8792859</ArticleId><ArticleId IdType="pubmed">35095837</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokhale Y., Patankar A., Holla U., Shilke M., Kalekar L., Karnik N.D., Bidichandani K., Baveja S., Joshi A. Dermatomyositis during COVID-19 Pandemic (A Case Series): Is there a Cause Effect Relationship? J. Assoc. Physicians India. 2020;68:20&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">33187031</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelenti L.R.M.P., Fraz&#xe3;o M.M.N., Maia M.P.M., Gomes F.H.R., de Carvalho L.M. Chronic arthritis related to SARS-CoV-2 infection in a pediatric patient: A case report. Braz. J. Infect. Dis. 2021;25:101585. doi: 10.1016/j.bjid.2021.101585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2021.101585</ArticleId><ArticleId IdType="pmc">PMC8120484</ArticleId><ArticleId IdType="pubmed">34043944</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinaei R., Pezeshki S., Parvaresh S., Sinaei R., Shiari R., Hassas Yeganeh M., Bazargn N., Gharaei N. Post SARS-CoV-2 infection reactive arthritis: A brief report of two pediatric cases. Pediatr. Rheumatol. Online J. 2021;19:89. doi: 10.1186/s12969-021-00555-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00555-9</ArticleId><ArticleId IdType="pmc">PMC8196291</ArticleId><ArticleId IdType="pubmed">34118941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Ailioaie C., Litscher G. Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis. Int. J. Mol. Sci. 2022;23:4268. doi: 10.3390/ijms23084268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084268</ArticleId><ArticleId IdType="pmc">PMC9029451</ArticleId><ArticleId IdType="pubmed">35457086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitouni J., Bursztejn A.C., Belloni Fortina A., Beauchet A., Di Lernia V., Lesiak A., Thomas J., Topkarci Z., Murashkin N., Brzezinski P., et al. Children with psoriasis and COVID-19: Factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry) J. Eur. Acad. Dermatol. Venereol. 2022;36:2076&#x2013;2086. doi: 10.1111/jdv.18361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.18361</ArticleId><ArticleId IdType="pmc">PMC9349726</ArticleId><ArticleId IdType="pubmed">35748102</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander A.J., Joshi A., Mehendale A. The Musculoskeletal Manifestations of COVID-19: A Narrative Review Article. Cureus. 2022;14:e29076. doi: 10.7759/cureus.29076.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.29076</ArticleId><ArticleId IdType="pmc">PMC9557238</ArticleId><ArticleId IdType="pubmed">36249619</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Roongta R., Mondal S., Sinha D., Sinhamahapatra P., Ghosh A., Chattopadhyay A. Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature. Reumatol. Clin. 2023;19:67&#x2013;73. doi: 10.1016/j.reuma.2022.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC9096625</ArticleId><ArticleId IdType="pubmed">35578636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Jat K.R. Post-COVID-19 Sequelae in Children. Indian J. Pediatr. 2023;90:605&#x2013;611. doi: 10.1007/s12098-023-04473-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-023-04473-4</ArticleId><ArticleId IdType="pmc">PMC9992903</ArticleId><ArticleId IdType="pubmed">36884145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Ailioaie C., Litscher G., Chiran D.A. Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic. Int. J. Mol. Sci. 2022;23:7719. doi: 10.3390/ijms23147719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23147719</ArticleId><ArticleId IdType="pmc">PMC9322892</ArticleId><ArticleId IdType="pubmed">35887067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B. RECOVER Mechanistic Pathways Task Force (2023). Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira G.L.V., Oliveira C.N.S., Pinzan C.F., de Salis L.V.V., Cardoso C.R.B. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Front. Immunol. 2021;12:635471. doi: 10.3389/fimmu.2021.635471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635471</ArticleId><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Troisi J., Venutolo G., Pujolassos Tany&#xe0; M., Delli Carri M., Landolfi A., Fasano A. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? World J. Gastroenterol. 2021;27:1406&#x2013;1418. doi: 10.3748/wjg.v27.i14.1406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i14.1406</ArticleId><ArticleId IdType="pmc">PMC8047540</ArticleId><ArticleId IdType="pubmed">33911464</ArticleId></ArticleIdList></Reference><Reference><Citation>Settanni C.R., Ianiro G., Ponziani F.R., Bibb&#xf2; S., Segal J.P., Cammarota G., Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J. Gastroenterol. 2021;27:7433&#x2013;7445. doi: 10.3748/wjg.v27.i43.7433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i43.7433</ArticleId><ArticleId IdType="pmc">PMC8613742</ArticleId><ArticleId IdType="pubmed">34887641</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D., Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res. 2020;285:198018. doi: 10.1016/j.virusres.2020.198018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198018</ArticleId><ArticleId IdType="pmc">PMC7217790</ArticleId><ArticleId IdType="pubmed">32430279</ArticleId></ArticleIdList></Reference><Reference><Citation>Azer S.A. COVID-19: Pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020;37:100738. doi: 10.1016/j.nmni.2020.100738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100738</ArticleId><ArticleId IdType="pmc">PMC7403867</ArticleId><ArticleId IdType="pubmed">32834902</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakaroun R.M., Massier L., Kovacs P. Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders? Nutrients. 2020;12:1082. doi: 10.3390/nu12041082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12041082</ArticleId><ArticleId IdType="pmc">PMC7230435</ArticleId><ArticleId IdType="pubmed">32295104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsounis E.P., Triantos C., Konstantakis C., Marangos M., Assimakopoulos S.F. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J. Virol. 2023;12:68&#x2013;90. doi: 10.5501/wjv.v12.i2.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v12.i2.68</ArticleId><ArticleId IdType="pmc">PMC10075050</ArticleId><ArticleId IdType="pubmed">37033148</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov P.V., Ghafari M., Beer M., Lythgoe K., Simmonds P., Stilianakis N.I., Katzourakis A. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 2023;21:361&#x2013;379. doi: 10.1038/s41579-023-00878-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00878-2</ArticleId><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak B.O., Eun B.W. COVID-19 in immunocompromised children and adolescents. Clin. Exp. Pediatr. 2023;66:182&#x2013;189. doi: 10.3345/cep.2022.00878.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/cep.2022.00878</ArticleId><ArticleId IdType="pmc">PMC10167403</ArticleId><ArticleId IdType="pubmed">37070297</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y., Monsalve D.M., Rojas M., Rodr&#xed;guez Y., Zapata E., Ram&#xed;rez-Santana C., Anaya J.M. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome. J. Infect. Dis. 2022;225:2155&#x2013;2162. doi: 10.1093/infdis/jiac017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Neves P.F.M.D., Lima S.S., Lopes J.D.C., Torres M.K.D.S., Vallinoto I.M.V.C., Bichara C.D.A., Dos Santos E.F., de Brito M.T.F.M., da Silva A.L.S., et al. Cytokine Profiles Associated with Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J.X., Agbana Y.L., Sun Z.S., Fei S.W., Zhao H.Q., Zhou X.N., Chen J.H., Kassegne K. Increased interleukin-6 is associated with long COVID-19: A systematic review and meta-analysis. Infect. Dis. Poverty. 2023;12:43. doi: 10.1186/s40249-023-01086-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-023-01086-z</ArticleId><ArticleId IdType="pmc">PMC10123579</ArticleId><ArticleId IdType="pubmed">37095536</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sadi R., Dharmaprakash V., Nighot P., Guo S., Nighot M., Do T., Ma T.Y. Bifidobacterium bifidum Enhances the Intestinal Epithelial Tight Junction Barrier and Protects against Intestinal Inflammation by Targeting the Toll-like Receptor-2 Pathway in an NF-&#x3ba;B-Independent Manner. Int. J. Mol. Sci. 2021;22:8070. doi: 10.3390/ijms22158070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158070</ArticleId><ArticleId IdType="pmc">PMC8347470</ArticleId><ArticleId IdType="pubmed">34360835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Litscher G. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges. Int. J. Mol. Sci. 2021;22:4942. doi: 10.3390/ijms22094942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094942</ArticleId><ArticleId IdType="pmc">PMC8124384</ArticleId><ArticleId IdType="pubmed">34066560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacorn M., Romero-Soto H.N., Levy S., Chen Q., Hourigan S.K. The Gut Microbiome of Children during the COVID-19 Pandemic. Microorganisms. 2022;10:2460. doi: 10.3390/microorganisms10122460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10122460</ArticleId><ArticleId IdType="pmc">PMC9783902</ArticleId><ArticleId IdType="pubmed">36557713</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Gilboa T., Ogata A.F., Senussi Y., Lazarovits R., Boribong B.P., Bartsch Y.C., Loiselle M., Rivas M.N., Porritt R.A., et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Investig. 2021;131:e149633. doi: 10.1172/JCI149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bradley E., Zeamer A.L., Cincotta L., Salive M.C., Dutta P., Mutaawe S., Anya O., Meza-Segura M., Moormann A.M., et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. 2021;6:e152346. doi: 10.1172/jci.insight.152346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancona G., Alagna L., Alteri C., Palomba E., Tonizzo A., Pastena A., Muscatello A., Gori A., Bandera A. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front. Immunol. 2023;14:1080043. doi: 10.3389/fimmu.2023.1080043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1080043</ArticleId><ArticleId IdType="pmc">PMC10030519</ArticleId><ArticleId IdType="pubmed">36969243</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau M.G., Barrett K.E. Role of the microbiota-gut-brain axis in postacute COVID syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 2023;324:G322&#x2013;G328. doi: 10.1152/ajpgi.00293.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00293.2022</ArticleId><ArticleId IdType="pmc">PMC10042594</ArticleId><ArticleId IdType="pubmed">36880667</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan J.F., O&#x2019;Riordan K.J., Cowan C.S.M., Sandhu K.V., Bastiaanssen T.F.S., Boehme M., Codagnone M.G., Cussotto S., Fulling C., Golubeva A.V., et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019;99:1877&#x2013;2013. doi: 10.1152/physrev.00018.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00018.2018</ArticleId><ArticleId IdType="pubmed">31460832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostick J.W., Schonhoff A.M., Mazmanian S.K. Gut microbiome-mediated regulation of neuroinflammation. Curr. Opin. Immunol. 2022;76:102177. doi: 10.1016/j.coi.2022.102177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.102177</ArticleId><ArticleId IdType="pmc">PMC9167715</ArticleId><ArticleId IdType="pubmed">35462279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Ailioaie C., Litscher G. Photobiomodulation in Alzheimer&#x2019;s Disease&#x2014;A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? Pharmaceutics. 2023;15:916. doi: 10.3390/pharmaceutics15030916.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15030916</ArticleId><ArticleId IdType="pmc">PMC10054386</ArticleId><ArticleId IdType="pubmed">36986776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorens S., Nava E., Mu&#xf1;oz-L&#xf3;pez M., S&#xe1;nchez-Larsen &#xc1;., Segura T. Neurological Symptoms of COVID-19: The Zonulin Hypothesis. Front. Immunol. 2021;12:665300. doi: 10.3389/fimmu.2021.665300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.665300</ArticleId><ArticleId IdType="pmc">PMC8107207</ArticleId><ArticleId IdType="pubmed">33981312</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyucu M., Yalcin Kehribar D., &#xc7;apraz M., &#xc7;apraz A., Arslan M., &#xc7;elik Z.B., Usta B., Birinci A., Ozgen M. The Relationship Between COVID-19 Disease Severity and Zonulin Levels. Cureus. 2022;14:e28255. doi: 10.7759/cureus.28255.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.28255</ArticleId><ArticleId IdType="pmc">PMC9491012</ArticleId><ArticleId IdType="pubmed">36158380</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Bataineh M.T., Henschel A., Mousa M., Daou M., Waasia F., Kannout H., Khalili M., Kayasseh M.A., Alkhajeh A., Uddin M., et al. Gut Microbiota Interplay With COVID-19 Reveals Links to Host Lipid Metabolism Among Middle Eastern Populations. Front. Microbiol. 2021;12:761067. doi: 10.3389/fmicb.2021.761067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.761067</ArticleId><ArticleId IdType="pmc">PMC8603808</ArticleId><ArticleId IdType="pubmed">34803986</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinold J., Farahpour F., Fehring C., Dolff S., Konik M., Korth J., van Baal L., Hoffmann D., Buer J., Witzke O., et al. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates with Severe COVID-19. Front. Cell. Infect. Microbiol. 2021;11:747816. doi: 10.3389/fcimb.2021.747816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.747816</ArticleId><ArticleId IdType="pmc">PMC8635721</ArticleId><ArticleId IdType="pubmed">34869058</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X., Zhang Y., Li Y., Wu Q., Wu J., Park S.K., Guo C., Lu J. Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases. BMC Microbiol. 2022;22:274. doi: 10.1186/s12866-022-02686-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-022-02686-9</ArticleId><ArticleId IdType="pmc">PMC9662111</ArticleId><ArticleId IdType="pubmed">36376804</ArticleId></ArticleIdList></Reference><Reference><Citation>Guido C.A., Lucidi F., Midulla F., Zicari A.M., Bove E., Avenoso F., Amedeo I., Mancino E., Nenna R., De Castro G., et al. Long-Covid Group of Department of Maternal Sciences. Neurological and psychological effects of long COVID in a young population: A cross-sectional study. Front. Neurol. 2022;13:925144. doi: 10.3389/fneur.2022.925144.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.925144</ArticleId><ArticleId IdType="pmc">PMC9428748</ArticleId><ArticleId IdType="pubmed">36062008</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider K.M., Blank N., Alvarez Y., Thum K., Lundgren P., Litichevskiy L., Sleeman M., Bahnsen K., Kim J., Kardo S., et al. The enteric nervous system relays psychological stress to intestinal inflammation. Cell. 2023;186:2823&#x2013;2838.e20. doi: 10.1016/j.cell.2023.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.05.001</ArticleId><ArticleId IdType="pmc">PMC10330875</ArticleId><ArticleId IdType="pubmed">37236193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidik S. Chronic stress can inflame the gut-now scientists know why. Nature. 2023;618:221&#x2013;222. doi: 10.1038/d41586-023-01700-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-01700-y</ArticleId><ArticleId IdType="pubmed">37231256</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>